Militia Capital Management LLC bought a new position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) during the 1st quarter, Holdings Channel.com reports. The fund bought 9,636 shares of the technology company’s stock, valued at approximately $1,693,000.
A number of other large investors have also modified their holdings of the business. Robeco Institutional Asset Management B.V. grew its holdings in Veeva Systems by 11.3% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 892,070 shares of the technology company’s stock worth $199,137,000 after acquiring an additional 90,703 shares during the period. Empire Life Investments Inc. lifted its holdings in Veeva Systems by 21.1% in the fourth quarter. Empire Life Investments Inc. now owns 37,054 shares of the technology company’s stock valued at $8,272,000 after acquiring an additional 6,453 shares during the period. Farther Finance Advisors LLC lifted its holdings in Veeva Systems by 217.2% in the fourth quarter. Farther Finance Advisors LLC now owns 10,470 shares of the technology company’s stock valued at $2,337,000 after acquiring an additional 7,169 shares during the period. Pictet Asset Management Holding SA boosted its position in shares of Veeva Systems by 14.2% during the 4th quarter. Pictet Asset Management Holding SA now owns 1,110,075 shares of the technology company’s stock worth $247,817,000 after purchasing an additional 137,965 shares in the last quarter. Finally, KBC Group NV boosted its position in shares of Veeva Systems by 180.2% during the 4th quarter. KBC Group NV now owns 201,140 shares of the technology company’s stock worth $44,900,000 after purchasing an additional 129,346 shares in the last quarter. 88.20% of the stock is owned by hedge funds and other institutional investors.
Veeva Systems Trading Up 0.2%
Shares of NYSE VEEV opened at $204.09 on Monday. The company’s 50-day moving average price is $178.56 and its 200 day moving average price is $180.04. Veeva Systems Inc. has a 52 week low of $148.05 and a 52 week high of $310.50. The stock has a market cap of $33.15 billion, a price-to-earnings ratio of 36.38, a PEG ratio of 0.88 and a beta of 0.92.
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on VEEV shares. BNP Paribas Exane reiterated an “outperform” rating and issued a $285.00 price target on shares of Veeva Systems in a report on Thursday, June 4th. Barclays decreased their price objective on shares of Veeva Systems from $250.00 to $235.00 and set an “overweight” rating on the stock in a report on Thursday, June 4th. Canaccord Genuity Group dropped their target price on shares of Veeva Systems from $235.00 to $220.00 and set a “hold” rating for the company in a report on Thursday, June 4th. BTIG Research reaffirmed a “buy” rating and issued a $340.00 target price on shares of Veeva Systems in a report on Thursday, June 4th. Finally, Raymond James Financial reiterated an “outperform” rating and set a $225.00 price target on shares of Veeva Systems in a research report on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $247.08.
View Our Latest Analysis on Veeva Systems
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Further Reading
- Five stocks we like better than Veeva Systems
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
